"Atlantic Neuroscience Institute, based at Overlook Medical Center, is the region’s leader in neuroscience care, offering a broad range of advanced neurological, neurosurgical and neurodiagnostic services. We are home to the Brain Tumor Center of New Jersey and the largest and most experienced CyberKnife program in the state. Overlook Medical Center is part of Atlantic Health System, one of the leading non-profit health care systems in NJ."

During the past decade, Atlantic Neuroscience Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atlantic Neuroscience Institute" #1 sponsor was "Ipsen" with 2 trials, followed by "Penumbra Inc." with 2 trials sponsored, "Biotie Therapies Inc." with 1 trials sponsored, "Psyadon Pharma" with 1 trials sponsored and "University of Miami" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlantic Neuroscience Institute" #1 collaborator was "Michael J. Fox Foundation for Parkinson's Research" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Acorda Therapeutics" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator and "Medical University of South Carolina" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Atlantic Neuroscience Institute" are "Brain Hemorrhage" (2 trials), "Cervical Dystonia" (2 trials), "Intracerebral Hemorrhage" (2 trials), "Cerebral Hemorrhage" (1 trials) and "Cerebral Parenchymal Hemorrhage" (1 trials). Many other conditions were trialed in "Atlantic Neuroscience Institute" in a lesser frequency.

Most popular intervention types in "Atlantic Neuroscience Institute" are "Drug" (6 trials), "Biological" (3 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Botulinum toxin type A" (2 trials), "Placebo" (2 trials), "Albumin" (1 trials), "Artemis + Medical Management" (1 trials) and "Artemis Neuro Evacuation Device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atlantic Neuroscience Institute" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Atlantic Neuroscience Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Atlantic Neuroscience Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Atlantic Neuroscience Institute, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".